Jim Simons Virax Biolabs Group LTD Transaction History

Renaissance Technologies LLC

  • $63.1 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
BUY
$0.34 - $0.68 $8,364 - $16,728
24,600 New
24,600 $10,000
Q4 2022

Feb 13, 2023
BUY
$0.57 - $28.6 $6,497 - $326,040
11,400 New
11,400 $8,000

About Virax Biolabs Group Ltd

VRAX Quotes by TradingView
  • Ticker VRAX
  • Exchange
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,374,100
  • Market Cap $22.4M
  • Description
  • Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits, and med-tech and PPE products for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company provides rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid te...
More about VRAX
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email